Literature DB >> 8739076

Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.

F Mannello1, G Bocchiotti, G Bianchi, F Marcheggiani, G Gazzanelli.   

Abstract

The frequency of gross cystic breast disease in premenopausal women and its possible association with increased breast cancer risk emphasises the importance of investigations relating to breast cyst fluid composition. In order to contribute to a better analysis of this medium, we have measured the presence of prostate-specific antigen immuno-reactivity in sixty-four human breast cyst fluids. Data analyses show that 35% of samples presented a level of this antigen < 0.05 micrograms/L, whereas 42 out of 64 cysts show a significant increase in the mean value of metabolically active apocrine cysts when compared to flattened cysts (p < 0.01). We report the first evidence that breast epithelium of gross cysts produces, secretes, and accumulates large amounts of prostate-specific antigen, a glycoprotein produced by prostatic tissue but recently detected in breast tumours, normal tissues, and during pregnancy. The production and intracystic accumulation of this serine protease in biosynthetically active apocrine type cyst can play a feasible role in the natural history gross cystic breast disease as well as in the mechanism of cyst formation, enlargement, and transformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739076     DOI: 10.1007/bf01806142

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  31 in total

1.  Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.

Authors:  C Naldoni; M Costantini; L Dogliotti; P Bruzzi; L Bucchi; G Buzzi; M Torta; A Angeli
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

2.  Biochemistry of cyst fluid in fibrocystic disease of the breast. Approach to classification and understanding of the mechanism of formation.

Authors:  R Molina; X Filella; M Herranz; M Prats; A Velasco; G Zanon; M J Martinez-Osaba; A M Ballesta
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry.

Authors:  J H van Krieken
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

4.  Abbott IMx evaluated for assay of prostate-specific antigen in serum.

Authors:  A M Dnistrian; M K Schwartz; C A Smith; J S Nisselbaum; W R Fair
Journal:  Clin Chem       Date:  1992-10       Impact factor: 8.327

5.  Isolation and characterization of a pepsin C zymogen produced by human breast tissues.

Authors:  L M Sánchez; J P Freije; A M Merino; F Vizoso; B Foltmann; C López-Otín
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

6.  Lipid-associated sialic acid levels in human breast cyst fluids.

Authors:  F Mannello; G Bocchiotti; R Troccoli; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

8.  Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.

Authors:  M A Levesque; E P Diamandis; H Yu; D J Sutherland
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors.

Authors:  M Monne; C M Croce; H Yu; E P Diamandis
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

10.  Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?

Authors:  N J Bundred; R R West; J O Dowd; R E Mansel; L E Hughes
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  5 in total

1.  Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease.

Authors:  M Malatesta; F Mannello; M Sebastiani; G Gazzanelli
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease.

Authors:  G H Borchert; H Yu; G Tomlinson; M Giai; R Roagna; R Ponzone; L Sgro; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 3.  Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?

Authors:  F Mannello; G Gazzanelli
Journal:  Breast Cancer Res       Date:  2001-05-10       Impact factor: 6.466

4.  Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.

Authors:  J Romppanen; R Keskikuru; V Kataja; M Eskelinen; V M Kosma; K Savolainen; M Uusitupa; I Mononen
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

5.  Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.

Authors:  R E Hall; J A Clements; S N Birrell; W D Tilley
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.